Let’s Get Proof is a blockchain-based crowdfunding platform that enhances the medical research funding process through dynamic review and precision funding. The platform addresses the disconnect between researchers, patients, and the public by fostering collaboration and transparency, enabling stakeholders to contribute expertise and insights to drive impactful medical innovations.
Funding
Funding not disclosed
Founders
Product
Problem
Medical research funding often lacks transparency and collaboration between researchers, patients, and the public. This disconnect can hinder the translation of research findings into practical applications and limit the impact of medical innovations. Traditional funding models may not effectively incorporate diverse perspectives and expertise.
Solution
Let's Get Proof is a platform designed to foster collaboration and transparency in medical research funding. It connects researchers, patients, and the public, enabling them to contribute expertise and insights throughout the research lifecycle. The platform promotes constructive discussions on study designs and findings, encourages clear communication of data and feedback, and empowers individuals with lived experiences to participate in the research process. By facilitating engagement and knowledge translation, Let's Get Proof aims to improve the impact of medical research and drive impactful medical innovations.
Target Audience
The primary audience includes medical researchers seeking funding and collaboration, patients interested in contributing to research, and members of the public who want to engage with medical advancements.
Features
- Working groups that allow researchers, patients, and the public to collaborate on research projects.
- A platform for promoting constructive discussions on study designs and findings.
- Tools for clear communication of data and feedback among stakeholders.
- Features that empower people with lived experiences to contribute their expertise.
- Medical research blogs covering various areas including stroke recovery, clinical psychedelic use, dementia, heart disease, and Alzheimer’s.